Torrent's chronic business grew at 13 per cent as compared to the Indian pharmaceutical market's (IPM) growth of 9 per cent ...

BEL share price slips despite strong margins and order inflows; Nomura downgrades, while UBS and JP Morgan stay bullish.

Shares of Torrent Pharma fell as much as 2.61% to Rs 3,717.50 apiece. They pared gains to trade 2.35% higher at Rs 3,708.20 ...

Zen Technologies' Q1 results were muted given a slowdown in order inflow momentum that persisted for a fifth quarter in a row ...

IndusInd Bank posts steep profit drop in Q1FY26 as asset quality deteriorates; see what brokerages recommend for investors.

Antique wrote in its note that a major trigger for Mazagon Dock will be the order for three additional Scorpene submarines, ...

Global brokerage Citi has maintained a 'Sell' rating with a target of ₹765 per share, according to reports. The brokerage ...

Elevated slippages led to higher credit costs, and brokerages expects return on assets (RoAs) to stay below 1 percent in the near term.

On the asset quality front, gross Stage 3 loans declined quarter-on-quarter, and credit costs came in better than expected.

SAIL, IndusInd Bank, Torrent Pharma, Lodha Developers, Motherson Wiring and more are on the radar of brokerages after Q1 ...

Of the 44 analysts that have coverage on IndusInd Bank, 24 of them continue to have a 'Sell' rating, 14 say 'Hold', while six ...

Torrent Pharma's India sales grew 11% year-on-year, led by out performance in the focused therapies as its chronic sales grew ...